Morgan Stanley Maintains Forecasts On Health Management Associates

According to Morgan Stanley, Health Management Associates (NYSE: HMA) 2011/2012 forecasts are maintained after bullish analyst day.

Morgan Stanley reported that for now, it remains comfortable with its current 2011/12 EBITDA forecasts of $809/$861 mm, respectively. “For its part, HMA re-affirmed its initial 2011 outlook provided in January, but the meeting tone was confident, as HMA highlighted its leading market position and expense management opportunity.”

Health Management Associates closed yesterday at $11.14.